Produkty 18376-53-9

CAS 18376-53-9 występuje w naszej ofercie pod nazwami: Stigmast-​5-​en-​7-​one, 3-​(acetyloxy)​-​, (3β)​-, ≥98%, ≥98%, 3β-(Acetyloxy)stigmast-5-en-7-one. Oferty producentów: Chemat, MedChemExpress. Dostępne opakowania: 5mg, 1 mg, 5 mg.

Stigmast-​5-​en-​7-​one, 3-​(acetyloxy)​-​, (3β)​-, ≥98%, ≥98%
Chemat
  • opakowanie: 5mg
  • Warianty: 1
od 3021,20
Zobacz produkt
3β-(Acetyloxy)stigmast-5-en-7-one
MedChemExpress
  • opakowanie: 1 mg, 5 mg
  • Warianty: 2
od 2999,28
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

[(3S,8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-7-oxo-1,2,3,4,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-yl] acetate (CAS 18376-53-9) to związek chemiczny o wzorze sumarycznym C31H50O3 i masie molowej 470.7 g/mol. Nazwa systematyczna IUPAC: [(3S,8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-7-oxo-1,2,3,4,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-yl] acetate. InChIKey: ZARLOMVQUZBFCL-MCJCEFGRSA-N.

Dane identyfikacyjne
Wzór sumarycznyC31H50O3
Masa molowa470.7 g/mol
Nazwa IUPAC[(3S,8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-7-oxo-1,2,3,4,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-yl] acetate
InChIKeyZARLOMVQUZBFCL-MCJCEFGRSA-N
SMILESCC[C@H](CC[C@@H](C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C(=O)C=C4[C@@]3(CC[C@@H](C4)OC(=O)C)C)C)C(C)C

Dane obliczone przez PubChem (NCBI)

Synonimy: 3|A-(Acetyloxy)stigmast-5-en-7-one, Stigmast-5-en-7-one, 3-(acetyloxy)-, (3beta)-, Stigmast-5-?en-?7-?one, 3-?(acetyloxy)?-?, (3|A)?-, orb1941432, 3|?-(Acetyloxy)stigmast-5-en-7-one, (24r)-3b-acetoxystigmast-5-en-7-one
Izomery (ten sam wzór sumaryczny)
[(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] dodecanoate C31H50O3
(2R)-2-[(1S,3R,6S,8R,11S,12S,15R,16R)-6-hydroxy-7,7,12,16-tetramethyl-15-pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]-6-methyl-5-methylideneheptanoic acid C31H50O3
2-[(3S,10S,13R,14R,17S)-3-hydroxy-4,4,10,13-tetramethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,5,6,7,11,12,17-octahydro-1H-cyclopenta[a]phenanthren-14-yl]acetic acid C31H50O3
methyl (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-3a-carboxylate C31H50O3
(2R)-2-[(3S,5R,10S,13R,14R,17R)-3-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methyl-5-methylideneheptanoic acid C31H50O3
methyl (4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate C31H50O3
(1R,4S,5S,8R,9R,12S,13S,16S)-8-[(E,2R)-6-methoxy-6-methylhept-4-en-2-yl]-5,9,17,17-tetramethyl-18-oxapentacyclo[10.5.2.01,13.04,12.05,9]nonadec-2-en-16-ol C31H50O3
methyl (1S,2R,4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-4a-carboxylate C31H50O3
[(7R,8R,9S,10R,11S,13S,14S,17S)-7,11,13-trimethyl-3-oxo-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl] undecanoate C31H50O3